Literature DB >> 11861727

Preoperative hemoglobin levels and the need for transfusion after prosthetic hip and knee surgery: analysis of predictive factors.

Jose A Salido1, Luis A Marín, Luis A Gómez, Pedro Zorrilla, Cristóbal Martínez.   

Abstract

BACKGROUND: Several studies have established a relationship between the preoperative hemoglobin level and the need for postoperative blood transfusion. We analyzed the relationship between preoperative hemoglobin levels, as well as other factors such as age, gender, weight, height, type and duration of the total joint replacement surgery, and the need for postoperative blood transfusion.
METHODS: A retrospective study of 296 patients treated with 370 procedures (209 total hip arthroplasties [56.5%] and 161 total knee arthroplasties [43.5%]) from 1994 to 1998 was carried out. A univariate analysis was performed to establish the relationship between all independent variables and the need for postoperative transfusion. Variables that were determined to have a significant relationship were included in a multivariate analysis.
RESULTS: The univariate analysis revealed a significant relationship between the need for postoperative blood transfusion and preoperative hemoglobin levels (p = 0.0001), duration of surgery (p = 0.0001), weight (p = 0.002), height (p = 0.019), and gender (p = 0.0056). However, the multivariate analysis identified a significant relationship only between the need for transfusion and the preoperative hemoglobin level (p = 0.0001) and weight (p = 0.011); height (p = 0.776) and gender (p = 0.122) were discounted as significant factors. Patients with a preoperative hemoglobin level of <130 g/L had a four times greater risk of having a transfusion than did those with a hemoglobin level between 130 and 150 g/L and a 15.3 times greater risk than did those with a hemoglobin level of >150 g/L.
CONCLUSIONS: The preoperative hemoglobin level (p = 0.0001) and weight of the patient (p = 0.011) were shown to predict the need for blood transfusion after hip and knee replacement.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861727     DOI: 10.2106/00004623-200202000-00008

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  53 in total

1.  Minimally invasive total hip arthroplasty using a transpiriformis approach: a preliminary report.

Authors:  Douglas J Roger; David Hill
Journal:  Clin Orthop Relat Res       Date:  2012-01-04       Impact factor: 4.176

Review 2.  On the role of iron therapy for reducing allogeneic blood transfusion in orthopaedic surgery.

Authors:  Manuel Muñoz; José Antonio García-Erce; Jorge Cuenca; Elvira Bisbe; Enrique Naveira
Journal:  Blood Transfus       Date:  2011-11-30       Impact factor: 3.443

3.  Can an Arthroplasty Registry Help Decrease Transfusions in Primary Total Joint Replacement? A Quality Initiative.

Authors:  David C Markel; Mark W Allen; Nicole M Zappa
Journal:  Clin Orthop Relat Res       Date:  2016-01       Impact factor: 4.176

4.  Autologous blood transfusion following total knee arthroplasty: is it always necessary?

Authors:  N Tellisi; R Kakwani; N Hulse; G Abusitta; N Ashammakhi; K A H Wahab
Journal:  Int Orthop       Date:  2006-06-08       Impact factor: 3.075

5.  Closed suction drains do not increase the blood transfusion rates in patients undergoing total knee arthroplasty.

Authors:  R O Sundaram; R W Parkinson
Journal:  Int Orthop       Date:  2006-09-01       Impact factor: 3.075

Review 6.  Peri-operative treatment of anaemia in major orthopaedic surgery: a practical approach from Spain.

Authors:  Elvira Bisbe; Misericordia Basora; María J Colomina
Journal:  Blood Transfus       Date:  2017-01-26       Impact factor: 3.443

7.  Lower blood loss after unicompartmental than total knee arthroplasty.

Authors:  Pierre-Emmanuel Schwab; Patricia Lavand'homme; Jean Cyr Yombi; Emmanuel Thienpont
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-07-26       Impact factor: 4.342

8.  Aspirin mono-therapy continuation does not result in more bleeding after knee arthroplasty.

Authors:  Pierre-Emmanuel Schwab; Patricia Lavand'homme; JeanCyr Yombi; Emmanuel Thienpont
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-10-29       Impact factor: 4.342

9.  Less blood loss under concomitant administration of tranexamic acid and indirect factor Xa inhibitor following total knee arthroplasty: a prospective randomized controlled trial.

Authors:  Sang Hak Lee; Kye-Youl Cho; Sumit Khurana; Kang-Il Kim
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-10-02       Impact factor: 4.342

10.  Use of a haemostatic matrix does not reduce blood loss in minimally invasive total knee arthroplasty.

Authors:  Pierre-Emmanuel Schwab; Emmanuel Thienpont
Journal:  Blood Transfus       Date:  2015-01-26       Impact factor: 3.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.